These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 10280556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER.
    N Engl J Med; 2005 Jan 27; 352(4):325-8. PubMed ID: 15673797
    [No Abstract] [Full Text] [Related]

  • 3. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West.
    Issue Brief Health Policy Track Serv; 2011 Jan 03; ():1-39. PubMed ID: 21374841
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Keeping prescription drugs safe and effective.
    Bryan PA.
    Am Fam Physician; 1974 Nov 03; 10(5):189-93. PubMed ID: 4421343
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2008 Jan 07; ():1-18. PubMed ID: 18345557
    [No Abstract] [Full Text] [Related]

  • 11. Off label drug promotion.
    Body Posit; 1998 Oct 07; 11(10):11. PubMed ID: 11365909
    [Abstract] [Full Text] [Related]

  • 12. The new drug marketing: a consumer protection perspective.
    Woodward D.
    Food Drug Law J; 1996 Oct 07; 51(4):637-50. PubMed ID: 11797733
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B.
    Food Drug Law J; 2008 Jan 05; 63(2):459-91. PubMed ID: 18561473
    [No Abstract] [Full Text] [Related]

  • 17. Major issues in marketing regulation.
    Pines WL.
    Food Drug Law J; 1997 Jan 05; 52(3):297-302. PubMed ID: 10343028
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of cosmetics that are also drugs.
    Greff JA.
    Food Drug Law J; 1996 Jan 05; 51(2):243-72. PubMed ID: 11820201
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.